Skip to main content

Advertisement

SpringerLink
Log in

A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

Choosing Wisely (CW)® was created by the American Board of Internal Medicine (ABIM) to promote patient–physician conversations about unnecessary medical interventions. Similarly, other countries created their own panels of experts called “CW® campaigns” which review recommendations submitted by that country’s oncology societies. We performed a scoping review to consolidate CW® recommendations from different groups with respect to breast cancer care.

Methods

A systematic search of Medline and Embase was designed by an information specialist for publications presenting CW® recommendations for breast cancer care practices from 2011–2020. We also reviewed the websites of all CW® campaigns and reference sections of each CW® recommendation. Two reviewers independently screened studies for inclusion and performed data extraction. Findings were summarized narratively.

Results

Review of ABIM CW® recommendations showed 19 breast cancer-related recommendations pertaining to; screening (n = 4), radiological staging (n = 2), treatment (n = 10), surveillance (n = 2), and miscellaneous (genetic testing; n = 1). Of 22 countries with CW® campaigns, 10 published recommendations for breast cancer. Over half (57%) of recommendations were supported by more than one country. No recommendations were refuted between campaigns. Two campaigns developed 3 novel recommendations on new topics, including chemotherapy in ductal carcinoma in situ (Italy) and comparison of screening imaging modalities (Portugal).

Conclusions

CW® recommendations focus on reducing overutilization of investigations and treatments. There was a high rate of consensus between different CW® campaigns. As health care systems globally move attention to reduce low-value care, further studies are required to address adherence to these current recommendations and develop new recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C et al (2015) Discrepancies between ESMO and NCCN breast cancer guidelines: an appraisal. Breast 24:513–523

    Article  PubMed  Google Scholar 

  2. Wennberg JE, Fisher ES, Skinner JS (2002) Geography and the debate over Medicare reform. Health Aff (Millwood). https://doi.org/10.1377/hlthaff.w2.96

    Article  Google Scholar 

  3. American Society of Clinical Oncology (2016) The state of cancer care in America, 2016: a report by the American Society of Clinical Oncology. J Oncol Pract 12(4):339–383. https://doi.org/10.1200/JOP.2015.010462

    Article  PubMed Central  Google Scholar 

  4. Wait S, Han D, Muthu V, Oliver K, Chrostowski S, Florindi F et al (2017) Towards sustainable cancer care: reducing inefficiencies, improving outcomes—a policy report from the all can initiative. J Cancer Policy 13:47–64

    Article  Google Scholar 

  5. Canadian Institute for Health Information (2017) Unnecessary care in Canada. CIHI, Ottawa, ON

    Google Scholar 

  6. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  PubMed  Google Scholar 

  7. American Board of Internal Medicine Foundation. Choosing Wisely® Clinician Lists, https://www.choosingwisely.org/clinician-lists/; 2020 [accessed 4 May 2020].

  8. Brody H (2010) Medicine’s ethical responsibility for health care reform-the top five list. N Engl J Med 362:283–285

    Article  CAS  PubMed  Google Scholar 

  9. Choosing Wisely® CanadaTM. Recommendations and Resources, by Specialty, https://choosingwiselycanada.org/recommendations/; 2020 [accessed 4 May 2020].

  10. Choosing Wisely® Italy, Raccomandazioni, https://choosingwiselyitaly.org/en/raccomandazioni/; 2020 [accessed 4 May 2020].

  11. Choosing Wisely® UK. Recommendations for clinicians 2016/18 2019, https://www.choosingwisely.co.uk/i-am-a-clinician/recommendations/#1476656358304-3b84e1d4-043d; 2020 [accessed 4 May 2020].

  12. Gemeinsam gut entscheiden. Die Top-5 Listen, https://www.gemeinsam-gut-entscheiden.at/; 2020 [accessed 4 May 2020].

  13. Sobre Choosing Wisely®. Recomendações, https://ordemdosmedicos.pt/choosing-wisely-portugal-escolhas-criteriosas-em-saude/recomendacoes/; 2018 [accessed 4 May 2020].

  14. Smarter Medicine- Choosing Wisely® Switzerland. «smarte» Listen für mehr Lebensqualität, https://www.smartermedicine.ch/de/top-5-listen/radio-onkologie.html; 2020, [accessed 4 may 2020].

  15. Pramesh C, Chaturvedi H, Reddy V, Saikia T, Ghoshal S, Pandit M et al (2019) Choosing Wisely® India: ten low-value or harmful practices that should be avoided in cancer care. Lancet Oncol 20(4):e218–e223. https://doi.org/10.1016/S1470-2045(19)30092-0

    Article  CAS  PubMed  Google Scholar 

  16. Tokuda, Y. Current Status of Choosing Wisely® in Japan. Journal of General and Family Medicine 2015; 16(1): 3–4. Retrieved from https://search.proquest.com/docview/2333548676/.

  17. Choosing Wisely® Australia. Recommendations, https://www.choosingwisely.org.au/recommendations; 2016 [accessed 4 May 2020].

  18. Choosing Wisely Aotearoa New Zealand. Tests, treatments & procedures health professionals should question, https://choosingwisely.org.nz/health-professionals/; 2020 [accessed 4 May 2020].

  19. Born K, Levinson W. "Choosing Wisely®: An International Campaign to Combat Overuse," To the Point, The Commonwealth Fund, https://www.commonwealthfund.org/blog/2017/choosing-wisely-international-campaign-combat-overuse?redirect_source=/publications/blog/2017/aug/choosing-wisely-combat-overuse; 2017 [accessed 4 May 2020].

  20. Schnipper LE, Smith TJ, Raghavan D, Blayney DW, Ganz PA, Mulvey TM et al (2012) American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol 30:1715–1724

    Article  PubMed  Google Scholar 

  21. Schnipper LE, Lyman GH, Blayney DW, Hoverman JR, Raghavan D, Wollins DS et al (2013) American Society of Clinical Oncology 2013 top five list in oncology. J Clin Oncol 31:4362–4387

    Article  PubMed  Google Scholar 

  22. Tesch M, Laing K (2018) Screening for new primary cancers in patients with metastatic breast cancer: a provincial analysis of the choosing Wisely® Canada recommendations. J Clin Oncol 36(15):e18817. https://doi.org/10.1200/JCO.2018.36.15_suppl.e18817

    Article  Google Scholar 

  23. Halasz L, Patel S, McDougall J, Fedorenko C, Sun Q, Goulart B et al (2019) Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: patterns of use and cost consequences among medicare beneficiaries. PLoS ONE 14(9):e0222904. https://doi.org/10.1371/journal.pone.0222904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Calderon E, Webb C, Kosiorek H, Gray MRJ, Cronin P, Anderson K et al (2019) Are we choosing wisely in elderly females with breast cancer? Am J Surg 218(6):1229–1233. https://doi.org/10.1016/j.amjsurg.2019.08.004

    Article  PubMed  Google Scholar 

  25. Srour M, Lee M, Walcott-Sapp S, Luu M, Chung A, Giuliano A et al (2019) Overuse of preoperative staging of patients undergoing neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol 26(10):3289–3294. https://doi.org/10.1245/s10434-019-07543-0

    Article  PubMed  Google Scholar 

  26. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) PRISMA Group: preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535

    Article  PubMed  PubMed Central  Google Scholar 

  27. Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1. https://doi.org/10.1186/2046-4053-4-1

    Article  PubMed  PubMed Central  Google Scholar 

  28. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D et al (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467–473

    Article  PubMed  Google Scholar 

  29. Ong W, Foroudi F, Milne R, Millar J (2019) Are we Choosing Wisely in radiation oncology practice-findings from an Australian Population-Based Study. Int J Radiat Oncol Biol Phys 104(5):1012–1016. https://doi.org/10.1016/j.ijrobp.2019.03.048

    Article  PubMed  Google Scholar 

  30. Corrigan K, Aksenov L, Paul A, Sharif-Askary B, Agarwal S, Kamal A (2019) Characterization of the recommendations in the Choosing Wisely initiative. Am J Med Qual 34(4):360–366. https://doi.org/10.1177/1062860618807298

    Article  PubMed  Google Scholar 

  31. Gunn J, Lemini R, Partain K, Yeager T, Almerey T, Attwood K et al (2020) Trends in utilization of sentinel node biopsy and adjuvant radiation in women ≥ 70. Breast J. https://doi.org/10.1111/tbj.13750

    Article  PubMed  PubMed Central  Google Scholar 

  32. Isaac A, Dalili D, Dalili D, Weber MA (2020) State-of-the-art imaging for diagnosis of metastatic bone disease Modernste Bildgebung zur Diagnose von Knochenmetastasen. Radiologe. https://doi.org/10.1007/s00117-020-00666-6

    Article  PubMed  PubMed Central  Google Scholar 

  33. Louie RJ, Gaber CE, Strassle PD, Gallagher KK, Downs-Canner SM, Ollila DW (2020) Trends in surgical axillary management in early stage breast cancer in elderly women: continued over-treatment. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-08388-8

    Article  PubMed  PubMed Central  Google Scholar 

  34. Lupichuk S, Tilley D, Surgeoner B, King K, Joy AA (2020) Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer. Can J Surg 63(2):E100–E109. https://doi.org/10.1503/cjs.003519

    Article  PubMed  PubMed Central  Google Scholar 

  35. Smith ME, Vitous CA, Hughes TM, Shubeck SP, Jagsi R, Dossett LA (2020) Barriers and facilitators to de-Implementation of the Choosing Wisely® guidelines for low-value breast cancer surgery. Ann Surg Oncol 27(8):2653–2663. https://doi.org/10.1245/s10434-020-08285-0

    Article  PubMed  PubMed Central  Google Scholar 

  36. Torres MA, Gogineni K, Howard DH (2020) Intensity-modulated radiation therapy in breast cancer patients following the release of a Choosing Wisely recommendation. J Natl Cancer Inst 112(3):314–317. https://doi.org/10.1093/jnci/djz198

    Article  PubMed  Google Scholar 

  37. Tran H, Jackson RS (2020) ASO author reflections: preoperative nomogram identifies patients for selective omission of SLNB in breast cancer—to promote implementation of the Choosing Wisely campaign recommendations. Ann Surg Oncol 27:2687–2688. https://doi.org/10.1245/s10434-020-08288-x

    Article  PubMed  Google Scholar 

  38. Attena F (2019) Too much medicine? scientific and ethical issues from a comparison between two conflicting paradigms. BMC Public Health 19(1):97. https://doi.org/10.1186/s12889-019-6442-9

    Article  PubMed  PubMed Central  Google Scholar 

  39. Mau K, Ringer R (2019) Age determinants for breast surgery: using the Choosing Wisely initiative for early-stage breast cancer treatment strategies. Clin J Oncol Nurs 23(1):97–98. https://doi.org/10.1188/19.CJON.97-98

    Article  PubMed  Google Scholar 

  40. Miles RC, Lee CI, Sun Q, Bansal A, Lyman GH, Specht JM et al (2019) Patterns of surveillance advanced imaging and serum tumor biomarker testing following launch of the Choosing Wisely initiative. J Natl Compr Canc Netw 17(7):813–820. https://doi.org/10.6004/jnccn.2018.7281

    Article  CAS  PubMed  Google Scholar 

  41. Neuner JM, Nattinger AB, Yen T, McGinley E, Nattinger M, Pezzin LE (2019) Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference? Breast Cancer Res Treat 176(1):205–215. https://doi.org/10.1007/s10549-019-05213-z

    Article  PubMed  PubMed Central  Google Scholar 

  42. Tesch M, Laing K (2019) Screening for new primary cancers in patients with metastatic breast cancer: a provincial analysis of the Choosing Wisely Canada recommendations. Curr Oncol 26(3):e309–e313. https://doi.org/10.3747/co.26.4289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Trapani D, Rajasekar AKA, Mathew A (2019) More options for adjuvant treatment of HER2-positive breast cancer: how to choose wisely? Int J Cancer 145(11):2901–2906. https://doi.org/10.1002/ijc.32418

    Article  CAS  PubMed  Google Scholar 

  44. Wallace AS, Keene KS, Williams CP, Jackson BE, Pisu M, Rocque GB (2019) Hypofractionated radiation in older women with breast cancer. Breast J 25(6):1206–1213. https://doi.org/10.1111/tbj.13444

    Article  CAS  PubMed  Google Scholar 

  45. Cheung MC, Tinmouth J, Austin PC, Fischer HD, Fung K, Singh S (2018) Screening for a new primary cancer in patients with existing metastatic cancer: a retrospective cohort study [published correction appears in CMAJ Open, 2018; 6(4):E567]. CMAJ Open 6(4):E538–E543. https://doi.org/10.9778/cmajo.20180045

    Article  PubMed  PubMed Central  Google Scholar 

  46. Enright K, Desai T, Sutradhar R, Gonzalez A, Powis M, Taback N et al (2018) Factors associated with imaging in patients with early breast cancer after initial treatment. Curr Oncol 25(2):126–132. https://doi.org/10.3747/co.25.3838

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Niska JR, Keole SR, Pockaj BA, Halyard MY, Patel SH, Northfelt DW et al (2018) Choosing wisely after publication of level I evidence in breast cancer radiotherapy. Breast Cancer (Dove Med Press) 10:31–37. https://doi.org/10.2147/BCTT.S153117

    Article  Google Scholar 

  48. Poorvu PD, Vaz-Luis I, Freedman RA, Lin NU, Barry WT, Winer EP et al (2018) Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States. Breast Cancer Res Treat 168(3):727–737. https://doi.org/10.1007/s10549-018-4659-4

    Article  CAS  PubMed  Google Scholar 

  49. Rao R, Ludwig K, Bailey L, Berry TS, Buras R, Degnim A et al (2018) Select choices in benign breast disease: an initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® campaign. Ann Surg Oncol 25(10):2795–2800. https://doi.org/10.1245/s10434-018-6584-5

    Article  PubMed  PubMed Central  Google Scholar 

  50. Schumacher JR, Neuman HB, Chang GJ, Kozower BD, Edge SB, Yu M et al (2018) A National study of the use of asymptomatic systemic imaging for surveillance following breast cancer treatment (AFT-01). Ann Surg Oncol 25(9):2587–2595. https://doi.org/10.1245/s10434-018-6496-4

    Article  PubMed  PubMed Central  Google Scholar 

  51. Seely JM, Appavoo S, Wadden N, Loisel Y, Scaranelo A (2018) Choosing Wisely Canada and diagnostic imaging: what level of evidence supports the recommendations? Can Assoc Radiol J 69(3):338–339. https://doi.org/10.1016/j.carj.2018.05.001

    Article  PubMed  Google Scholar 

  52. Trooboff SW, Kang R, Margenthaler J et al (2018) Choosing Wisely: optimizing routine workup for the newly diagnosed breast cancer patient. Curr Breast Cancer Rep 10:62–73. https://doi.org/10.1007/s12609-018-0268-9

    Article  CAS  Google Scholar 

  53. Wallace AS, Fiveash JB, Williams CP, Kvale E, Psiu M, Jackson BE et al (2018) Choosing Wisely at the end of life: use of shorter courses of palliative radiation therapy for bone metastasis. Int J Radiat Oncol Biol Phys 102(2):320–324. https://doi.org/10.1016/j.ijrobp.2018.05.061

    Article  PubMed  Google Scholar 

  54. Wallace AS, Nelson JP, Wang Z, Dale PS, Biedermann GB (2018) In support of the Choosing Wisely campaign: perceived higher risk leads to unnecessary imaging in accelerated partial breast irradiation? Breast J 24(1):12–15. https://doi.org/10.1111/tbj.12832

    Article  CAS  PubMed  Google Scholar 

  55. Baxi SS, Kale M, Keyhani S, Roman BR, Yang A, Derosa AP et al (2017) Overuse of health care services in the management of cancer: a systematic review. Med Care 55(7):723–733. https://doi.org/10.1097/MLR.0000000000000734

    Article  PubMed  PubMed Central  Google Scholar 

  56. Henry NL, Braun TM, Breslin TM, Gorski DH, Silver SM, Griggs JJ (2017) Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry. Cancer 123(15):2975–2983. https://doi.org/10.1002/cncr.30674

    Article  PubMed  Google Scholar 

  57. Rocque G, Blayney DW, Jahanzeb M, Knape A, Markham MJ, Pham T et al (2017) Choosing Wisely in oncology: are we ready for value-based care? J Oncol Pract 13(11):e935–e943. https://doi.org/10.1200/JOP.2016.019281

    Article  PubMed  Google Scholar 

  58. Tran K, Rahal R, Fung S, Lockwood G, Louzado C, Xu J et al (2017) Choosing wisely in cancer control across Canada-a set of baseline indicators. Curr Oncol 24(3):201–206. https://doi.org/10.3747/co.24.3643

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Welsh JL, Hoskin TL, Day CN, Habermann EB, Goetz MP, Boughey JC (2017) Predicting nodal positivity in women 70 years of age and older with hormone receptor-positive breast cancer to aid incorporation of a society of surgical oncology choosing wisely guideline into clinical practice. Ann Surg Oncol 24(10):2881–2888. https://doi.org/10.1245/s10434-017-5932-1

    Article  PubMed  Google Scholar 

  60. Freitas V, Crystal P, Kulkarni SR, Ghai S, Bukhanov K, Escallon J et al (2016) The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: is there a role to choose wisely patients for sentinel node biopsy? Cancer Med 5(6):1031–1036. https://doi.org/10.1002/cam4.663

    Article  PubMed  PubMed Central  Google Scholar 

  61. Kamal A, Zhang T, Power S, Marcom PK (2016) Is advanced imaging in early-stage breast cancer ever warranted? reconciling clinical judgment with common quality measures. J Natl Compr Canc Netw 14(8):993–998. https://doi.org/10.6004/jnccn.2016.0106

    Article  PubMed  Google Scholar 

  62. Landercasper J, Bailey L, Berry TS, Buras RR, Degnim AC, Fayanju OM et al (2016) Measures of appropriateness and value for breast surgeons and their patients: The American Society of Breast Surgeons Choosing Wisely® initiative. Ann Surg Oncol 23(10):3112–3118. https://doi.org/10.1245/s10434-016-5327-8

    Article  PubMed  PubMed Central  Google Scholar 

  63. Morgan DM, Main E, Gee RE (2016) The Goldilocks Quandary of Health Care Resources: too little, too much, or just right? Obstet Gynecol 127(6):1039–1044. https://doi.org/10.1097/AOG.0000000000001426

    Article  PubMed  Google Scholar 

  64. Pezzin LE, Laud P, Neuner J, Yen TW, Nattinger AB (2016) A statewide controlled trial intervention to reduce use of unproven or ineffective breast cancer care. Contemp Clin Trials 50:150–156. https://doi.org/10.1016/j.cct.2016.08.005

    Article  PubMed  PubMed Central  Google Scholar 

  65. Tran K, Rahal R, Brundage M, Fung S, Louzado C, Milosevic M et al (2016) Use of low-value radiotherapy practices in Canada: an analysis of provincial cancer registry data. Curr Oncol 23(5):351–355. https://doi.org/10.3747/co.23.3359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Warr D, DeAngelis C, Chow E (2016) Can patient risk factors outperform antiemetic guidelines?: Choosing Wisely. JAMA Oncol 2(2):232–233. https://doi.org/10.1001/jamaoncol.2015.3757

    Article  PubMed  Google Scholar 

  67. Extermann M (2015) Systemic treatment of older breast cancer patients: Choosing Wisely. Breast Diseases 26(4):287–290. https://doi.org/10.1016/j.breastdis.2015.10.041

    Article  Google Scholar 

  68. Hahn EE, Tang T, Lee JS, Munoz-Plaza C, Adesina JO, Shen E et al (2015) Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. J Oncol Pract 11(3):e320–e328. https://doi.org/10.1200/JOP.2014.002998

    Article  PubMed  PubMed Central  Google Scholar 

  69. Makarov DV, Soulos PR, Gold HT, Yu JB, Sen S, Ross JS et al (2015) Regional-level correlations in inappropriate imaging rates for prostate and breast cancers: potential implications for the choosing Wisely campaign. JAMA Oncol 1(2):185–194. https://doi.org/10.1001/jamaoncol.2015.37

    Article  PubMed  PubMed Central  Google Scholar 

  70. Ramsey SD, Fedorenko C, Chauhan R, McGee R, Lyman GH, Kreizenbeck K et al (2015) Baseline estimates of adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely initiative among patients with cancer enrolled with a large regional commercial health insurer. J Oncol Pract 11(4):338–343. https://doi.org/10.1200/JOP.2014.002717

    Article  PubMed  Google Scholar 

  71. Simos D, Hutton B, Clemons M (2015) Are physicians Choosing Wisely when imaging for distant metastases in women with operable breast cancer? J Oncol Pract 11(1):62–68. https://doi.org/10.1200/JOP.2014.000125

    Article  PubMed  Google Scholar 

  72. Simos D, Hutton B, Graham ID, Arnaout A, Caudrelier JM, Clemons M (2015) Imaging for metastatic disease in patients with newly diagnosed breast cancer: are doctor’s perceptions in keeping with the guidelines? J Eval Clin Pract 21(1):67–73. https://doi.org/10.1111/jep.12240

    Article  PubMed  Google Scholar 

  73. Ellsworth SG, Alcorn SR, Hales RK, McNutt TR, DeWeese TL, Smith TJ (2014) Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution. Int J Radiat Oncol Biol Phys 89(5):1100–1105. https://doi.org/10.1016/j.ijrobp.2014.04.028

    Article  PubMed  PubMed Central  Google Scholar 

  74. Jagsi R, Griffith KA, Heimburger D, Walker EM, Grills IS, Boike T et al (2014) Choosing wisely? patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. Int J Radiat Oncol Biol Phys 90(5):1010–1016. https://doi.org/10.1016/j.ijrobp.2014.09.027

    Article  PubMed  Google Scholar 

  75. Sullivan, MG. Single-drug chemo for breast cancer makes Choosing Wisely list. Oncology Report, 2013; 15. Accessed here on July 14, 2020: https://www.mdedge.com/obgyn/article/78587/breast-cancer/single-drug-chemo-breast-cancer-makes-ascos-choosing-wisely-list

  76. Ramsey SD, Fedorenko C, Chauhan R et al (2015) Baseline estimates of adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely initiative among patients with cancer enrolled with a large regional commercial health insurer. J Oncol Pract 11:338–343

    Article  PubMed  Google Scholar 

  77. Proqualis. Proqualis Publications, https://proqualis.net/search/site/?f[0]=im_field_secoes%3A423; 2014 [accessed 4 May 2020].

  78. Levinson W, Kallewaard M, Bhatia RS (2015) On behalf of the Choosing Wisely® International Working Group, et al ‘Choosing Wisely’: a growing international campaign. BMJ Qual Saf 24:167–174

    Article  PubMed  Google Scholar 

  79. Bertelsmann Stiftung. International physicians’ initiative against medical overuse, https://www.bertelsmann-stiftung.de/en/our-projects/patients-with-impact/project-topics/choosing-wisely; 2020 [accessed 4 May 2020].

  80. 1000 Lives O Fywydau. Making Choices Together, https://www.1000livesplus.wales.nhs.uk/making-choices-together; 2019 [accessed 4 May 2020].

  81. Prescrire in English. Overmedication, https://english.prescrire.org/en/80/159/PositionsList.aspx; 2008 [accessed 4 May 2020].

  82. Rocque GB, Williams CP, Jackson BE et al (2017) Choosing Wisely: opportunities for improving value in cancer care delivery? J Oncol Pract 13:43

    Article  Google Scholar 

  83. Niska J, Keole S, Pockaj B, Halyard M, Wong W, Patel S et al (2015) Impact of level I evidence on radiation therapy utilization in breast cancer. Int J Radiat Oncol Biol Phys 93(3):E12–E12. https://doi.org/10.1016/j.ijrobp.2015.07.573

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Brianne Bota for her editorial assistance during the initial phase of this project.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada

    Hely Shah & Mark Clemons

  2. Division of Medical Oncology, The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa, ON, Canada

    Julian Surujballi, Arif Ali Awan, Mashari Jemaan Alzahrani & Mark Clemons

  3. The University of Ottawa, School of Epidemiology and Public Health, and Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Brian Hutton & Mark Clemons

  4. Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada

    Angel Arnaout

  5. The Ottawa Hospital, Ottawa, ON, Canada

    Risa Shorr

  6. Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Lisa Vandermeer

Authors
  1. Hely Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julian Surujballi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arif Ali Awan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brian Hutton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angel Arnaout
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Risa Shorr
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lisa Vandermeer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mashari Jemaan Alzahrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mark Clemons
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Clemons.

Ethics declarations

Conflicts of interest

Dr. Awan and Dr. Clemons report participating in the Novartis Canada Advisory Board on the use of Ribociclib. Dr. Hutton reports personal fees from Cornerstone Research, outside the submitted work. The remaining authors declare that they have no conflicts of interest.

Research Involving human participants

This scoping review did not involve human participation.

Informed consent

This scoping review did not involve individual participation, and therefore, informed consent is not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (docx 44 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, H., Surujballi, J., Awan, A.A. et al. A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management. Breast Cancer Res Treat 185, 533–547 (2021). https://doi.org/10.1007/s10549-020-06009-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-020-06009-2

Keywords

Search

Navigation